Skip to main content
Top

Drugs

Issue 8/2017

Content (10 Articles)

Medical Expulsive Therapy: Is It Time to SUSPEND Judgement?

  • Current Opinion

Tarik Amer, Gareth Jones, Omar Aboumarzouk

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer

  • Current Opinion

Saoirse O. Dolly, Dearbhaile C. Collins, Raghav Sundar, Sanjay Popat, Timothy A. Yap

Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management

  • Therapy in Practice

Alicia Santos, Eugenia Resmini, Juan Carlos Pascual, Iris Crespo, Susan M. Webb

Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions

  • Review Article

Marie Lund, Tonny Studsgaard Petersen, Kim Peder Dalhoff

Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis

  • Review Article

A. Nandoskar, J. Raffel, A. S. Scalfari, T. Friede, R. S. Nicholas

Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4

  • Adis Drug Evaluation

Zaina T. Al-Salama, Emma D. Deeks

Naldemedine: First Global Approval

  • AdisInsight Report

Anthony Markham

Avelumab: First Global Approval

  • AdisInsight Report

Esther S. Kim

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

  • Erratum

Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images